« This can take weeks or months. »
Regine Steinauer, Head of the Addiction Service of the Basel-Stadt Department of Health
The launch of the controlled sale of cannabis in pharmacies in Basel, scheduled for next Thursday, has been postponed until further notice. The products intended for this pilot project do not meet the required biological criteria, because they contain residues of phytosanitary products, reports the Swiss Radio Television (RTS).
The cannabic products grown by the firm Pure Production in Zeiningen (AG), commissioned by the canton of Basel-Stadt, have narrowly failed the quality test, said Friday the cantonal department of health.*
They will now be analyzed by an independent laboratory. In addition, the authorities will study the possibility of using other cannabic products from the same firm or other producers.*
The residues of phytosanitary products discovered on the cannabis provided by the company commissioned are not allowed in the organic mode of cultivation, says Regine Steinauer, head of the service of addictions of the department of health of Basel-City.*
No deadline*
The duration of the postponement is not yet known. “It could be weeks or months,” adds Regine Steinauer. In mid-August, the canton had announced that the controlled sale of cannabis in nine selected pharmacies would begin on September 15, as part of the first pilot project of its kind in Switzerland.*
A total of 370 selected regular cannabis consumers are expected to participate. Approximately 700 people have registered to participate in the study. The canton will contact the participants from mid-September.*
** image
*** ndlr. : –.
